COST Actions: fostering collaborative research for rare diseases

Lancet Neurol. 2019 Nov;18(11):989-991. doi: 10.1016/S1474-4422(19)30366-7.
No abstract available

Publication types

  • Letter

MeSH terms

  • Cooperative Behavior
  • Education / organization & administration
  • Genetic Therapy / methods
  • Humans
  • Hyperlipoproteinemia Type II / genetics
  • Hyperlipoproteinemia Type II / therapy
  • Information Services / organization & administration*
  • Muscular Atrophy, Spinal / genetics
  • Muscular Atrophy, Spinal / therapy
  • Muscular Dystrophy, Duchenne / genetics
  • Muscular Dystrophy, Duchenne / therapy
  • Oligonucleotides, Antisense / therapeutic use
  • Publishing
  • RNA Splicing / drug effects
  • RNA, Antisense / therapeutic use
  • Rare Diseases* / therapy
  • Research

Substances

  • Oligonucleotides, Antisense
  • RNA, Antisense